Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $822.37 ($82K) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Scheduled sale ($82k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $816.58 | 7 | $6K | 7.0% |
| 2 | $817.49 | 13 | $11K | 13.0% |
| 3 | $818.47 | 27 | $22K | 27.0% |
| 4 | $819.48 | 32 | $26K | 32.0% |
| 5 | $820.55 | 5 | $4K | 5.0% |
| 6 | $821.61 | 1 |
| $822 |
| 1.0% |
| 7 | $822.37 | 9 | $7K | 9.0% |
| 8 | $823.34 | 6 | $5K | 6.0% |
| Total | $819.31 avg | 100 | $82K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |